Stock SMTI SANARA MEDTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sanara MedTech Inc.

Equities

SMTI

US79957L1008

Pharmaceuticals

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-15 pm EDT 		5-day change 1st Jan Change
34.06 USD +14.07% Intraday chart for Sanara MedTech Inc. +3.65% -17.13%
May. 14 Transcript : Sanara MedTech Inc., Q1 2024 Earnings Call, May 14, 2024
May. 13 Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down MT

Business Summary

Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. It markets several products for surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products, CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus Advanced Viable Bone Matrix (ALLOCYTE Plus), BIASURGE, FORTIFY TRG Tissue Repair Graft (FORTIFY TRG), and FORTIFY FLOWABLE Extracellular Matrix (FORTIFY FLOWABLE) are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. CellerateRX Surgical products, TEXAGEN products, FORTIFY TRG and FORTIFY FLOWABLE are used in specialties, including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and others.

Number of employees: 108

Sales per Business

USD in Million2022Weight2023Weight Delta
Soft Tissue Repair Products
84.4 %
- - 55 84.4 % -
Bone Fusion Products
15.3 %
- - 10 15.3 % -
Royalty
0.3 %
0 0.4 % 0 0.3 % 0.00%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
46 100.0 % 65 100.0 % +41.77%

Managers

Managers TitleAgeSince
Michael McNeil DFI
 Director of Finance/CFO 59 18-04-10
Prodromos Ververeli CTO
 Chief Tech/Sci/R&D Officer - 22-12-31
Rebecca E. Mcmahon CTO
 Chief Tech/Sci/R&D Officer 39 21-06-30
Susan Dieter CTO
 Chief Tech/Sci/R&D Officer - -
Bill Fitzgerald CMP
 Compliance Officer - -
Callon Nichols IRC
 Investor Relations Contact - 19-07-31
Seth Yon PRN
 Corporate Officer/Principal - 17-12-31
Tricia Matteson SAM
 Sales & Marketing - -
Carla Day SAM
 Sales & Marketing - -
W. David Lee PRN
 Corporate Officer/Principal - 22-12-31

Members of the board

Members of the board TitleAgeSince
Eric Tanzberger BRD
 Director/Board Member 55 21-12-31
Roszell Mack BRD
 Director/Board Member 57 21-12-31
Eric Major BRD
 Director/Board Member 55 23-05-31
James Stuckert BRD
 Director/Board Member 86 15-09-20
Robert Desutter BRD
 Director/Board Member 55 20-10-11
Ron Nixon CEO
 Chief Executive Officer 68 19-03-14
Sara Ortwein BRD
 Director/Board Member 65 20-12-17
Ann Salamone BRD
 Director/Board Member 73 19-08-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 8,625,201 3,443,359 ( 39.92 %) 0 39.92 %

Shareholders

NameEquities%Valuation
The Catalyst Group, Inc
40.73 %
3,511,790 40.73 % 113 M $
James Stuckert
11.17 %
963,532 11.17 % 31 M $
Denny Howell
5.687 %
490,394 5.687 % 16 M $
BlackRock Advisors LLC
2.185 %
188,405 2.185 % 6 M $
Vanguard Fiduciary Trust Co.
1.675 %
144,394 1.675 % 5 M $
Geode Capital Management LLC
0.9196 %
79,295 0.9196 % 3 M $
STATE STREET CORPORATION
0.6193 %
53,399 0.6193 % 2 M $
Zach Fleming
0.5666 %
48,854 0.5666 % 2 M $
Ron Nixon
0.5299 %
45,696 0.5299 % 1 M $
Northern Trust Investments, Inc.(Investment Management)
0.3272 %
28,215 0.3272 % 908 805 $

Company contact information

Sanara MedTech, Inc.

1200 Summit Avenue Suite 414

76102, Fort Worth

+

http://www.sanaramedtech.com
address Sanara MedTech Inc.(SMTI)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
34.06 USD
Average target price
44 USD
Spread / Average Target
+29.18%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SANARA MEDTECH INC. Stock Sanara MedTech Inc.
-17.13% 294M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.37% 595B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.60% 367B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.83% 334B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.83% 239B
NOVARTIS AG Stock Novartis AG
+9.93% 211B
ROCHE HOLDING AG Stock Roche Holding AG
-6.95% 203B
AMGEN INC. Stock Amgen Inc.
+10.77% 171B
PFIZER, INC. Stock Pfizer, Inc.
+0.10% 163B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. SMTI Stock
  4. Company Sanara MedTech Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW